Adverse Childhood Experiences, Adaptation and Breast Cancer
NCT ID: NCT05843539
Last Updated: 2025-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2022-04-12
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
ACEs leave physiological and epigenetic impact that can nowadays be easily evaluated, thus providing additional evidence between adversity, physiological and epigenetic vulnerability and the ability to adapt to life's challenges such as cancer. Life history changes are mediated by changes in cellular mechanisms affecting genome expression. It is currently widely demonstrated that ACEs increases epigenetic modifications.
The interest of this project is therefore to highlight the psychological consequences related to the occurrence of cancer in the developmental history (in terms of adversities) of patients who have completed adjuvant chemotherapy for breast cancer, taking into account the patients' previous attachments, resilience, fear of recurrence and perceived fatigue in order to consider their interactions and their effects on their psychological health and ultimately on their quality of life.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Psychological Factors and Oncological Outcomes of Triple-negative Breast Cancer
NCT04669522
Metastatic Breast Carcinoma and Women Sexual Quality of Life
NCT03408769
Couples' QOL in Metastatic Breast Cancer
NCT05636943
ADIE-BC - Aligning Dimensions of Interoceptive Experience in Breast Cancer Survivors
NCT06954532
The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast Cancer
NCT06690645
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biological and epigenetic measures
This study also includes an exploratory biological ancillary study that aims to identify the gene expression variations that are determinant in terms of vulnerability/protection (cytogenetic and transcriptome), through the measurement of the level of biological chronic stress and epigenetic methylations of the NR3C1 and FKBP5 genes, in relation to adversity in childhood And to show the convergence between self-reported measures related to the presence of ACEs and attachment disorders with assays of chronic stress and epigenetic biomarkers.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be considered in remission
* Be over 18 years of age
* Literate (able to understand the information and complete the questionnaire independently)
* Agree to participate in the project and sign the informed consent form
Exclusion Criteria
* Be a protected adult, under guardianship or curators
* Be undergoing oncological treatment
* Have a lack of autonomy making it impossible to complete the questionnaire online
* Have had or have begun psychotherapeutic treatment
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ligue contre le cancer, France
OTHER
University of Lorraine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christine Rotonda
Director of the research pole in Pierre Janet Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marion Trousselard, Pr
Role: PRINCIPAL_INVESTIGATOR
UR 4360 APEMAC, University of Lorraine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ur 4360 Apemac
Metz, Lorraine, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A02850-36
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.